Not applicableStudy completedNCT00711139What this trial is testingLong-term Safety and Tolerability of AFFITOPE AD01Who this might be right forAlzheimer's Disease Affiris AG 22
Testing effectiveness (Phase 2)Study completedNCT00711230What this trial is testingRepeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve PatientsWho this might be right forHIV Infection Genetic Immunity 36
Testing effectiveness (Phase 2)Looking for participantsNCT04329065What this trial is testingConcurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast CancerWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8 University of Washington 25
Not applicableUnknownNCT04579822What this trial is testingMaternal and Fetal Outcomes Following Influenza Vaccination in PregnancyWho this might be right forPregnancy RelatedInfluenza Virus Vaccine Adverse Reaction Sungkyunkwan University 300,000
Not applicableStudy completedNCT04832022What this trial is testingLongitudinal Follow-up of Patients With Chronic Inflammatory Rheumatisms (CIRs) Vaccinated Against COVID-19 Compared to Patients Refusing VaccinationWho this might be right forRheumatic DiseasesSARS-CoV InfectionCOVID-19 University Hospital, Montpellier 397
Testing effectiveness (Phase 2)Study completedNCT03589807What this trial is testing2013/2017 H7N9 Prime-Boost IntervalWho this might be right forAvian InfluenzaInfluenza Immunisation National Institute of Allergy and Infectious Diseases (NIAID) 180
Early research (Phase 1)Study completedNCT03827395What this trial is testingSafety Study of Hepatitis E Vaccine (HEV239)Who this might be right forHepatitis EImmunisation National Institute of Allergy and Infectious Diseases (NIAID) 25
Not applicableUnknownNCT03700281What this trial is testingInvestigating the Effectiveness of a Seasonal Influenza Vaccination Promotion Campaign for Members of a Non-Profit, Community-Based Health Insurance Plan: 2018-2019Who this might be right forInfluenza, Vaccination The University of Texas Health Science Center at Tyler 22,584
Post-approval studies (Phase 4)UnknownNCT01830257What this trial is testingExplore Active Surveillance Mode of the Community's Adverse Event Following Immunization(AEFI)Who this might be right forAdverse Reaction to Drug Beijing Center for Disease Control and Prevention 1,000
Large-scale testing (Phase 3)Study completedNCT00678301What this trial is testingPrimary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™Who this might be right forInfections, Streptococcal GlaxoSmithKline 365
Not applicableActive Not RecruitingNCT07251465What this trial is testingLearn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting PneumoniaWho this might be right forPneumonia Pfizer 846,279
Early research (Phase 1)Study completedNCT02031198What this trial is testing18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Axon Neuroscience SE 25
Not applicableStudy completedNCT00050063What this trial is testingEffects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV DrugsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 78
Not applicableLooking for participantsNCT07171164What this trial is testingEvaluate Community-Based Measures to Increase RSV Vaccine Use Among Latino AdultsWho this might be right forOlder Adults Without Any Specific Clinical ConditionSocial NetworksRSV Immunization+1 more University of California, San Francisco 750
Post-approval studies (Phase 4)Study completedNCT00774995What this trial is testingImmune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine.Who this might be right forHepatitis B GlaxoSmithKline 49
Early research (Phase 1)Study completedNCT00000977What this trial is testingActive Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and ToxicityWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 52
Testing effectiveness (Phase 2)Study completedNCT00116467What this trial is testingVaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous LeukemiaWho this might be right forAcute Myelogenous Leukemia Cell Genesys 55
Early research (Phase 1)Ended earlyNCT01810016What this trial is testingNY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic MelanomaWho this might be right forUnresectable or Metastatic Melanoma Ludwig Institute for Cancer Research 8
Post-approval studies (Phase 4)Active Not RecruitingNCT06825312What this trial is testingImmunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese EncephalitisWho this might be right forJapanese Encephalitis Vaccine Liaoning Chengda Biotechnology CO., LTD 600
Testing effectiveness (Phase 2)Study completedNCT03617328What this trial is testingVaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV MelanomaWho this might be right forMelanoma Craig L Slingluff, Jr 33